Why is Natco Pharma falling/rising?

As of 17-Jul, Natco Pharma Ltd. is experiencing a price increase, currently at 1,032.95, reflecting a rise of 12.65 or 1.24%. The stock has shown strong performance recently, gaining 7.4% over the last four days and outperforming its sector by 0.82% today. It reached an intraday high of Rs 1059, indicating positive momentum. Despite a year-to-date decline of 25.53%, the stock has performed well in the short term, with a 1-week return of 3.34% compared to a decline of 1.12% in the Sensex. The company boasts high management efficiency with a return on equity (ROE) of 15.57% and a low debt-to-equity ratio, contributing to its healthy long-term growth prospects.
Broader Market Context: In the context of the broader market, Natco Pharma's recent short-term performance contrasts sharply with the Sensex, which has shown a modest increase of 0.83% over the past month. The stock's strong returns in the short term, coupled with a significant increase in operating profit and a favorable PEG ratio of 0.3, suggest that it is trading at a discount compared to its peers. Furthermore, high institutional holdings at 21.33% indicate confidence from larger investors, which may support the stock's upward movement despite its longer-term underperformance.